ARCHIVES

About Face; NCI To Keep Preclinical AIDS Drug Development

This article is from The Cancer Letter archive.

Vol. 12 No. 48 | December 12, 1986

Download PDF Visit The Full Archive

Related Articles

NCI Advisors Approve Plans To Continue Current Research Programs.

July 3, 2008

EntreMed Begins Phase I/II Trial For Endostatin.

July 27, 2001

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

December 19, 2014

NCAB Disproves W. Virginia Construction Grant, Okays Funding Three New, Three Carryover Awards

May 24, 1985

In This Issue: The controversy Over “Cancer Undefeated”

June 6, 1997

Buenos Aires Academy Denies Argentina Prosecutes Scientist

July 28, 1978